Evelyn Fessler
- Oncology top 2%
- Molecular Biology top 5%
- Cancer Research top 2%
- Pathology and Forensic Medicine top 2%
- Immunology top 10%
- Co-authors
- Jan Paul MedemaFelipe de Sousa e MeloLouis VermeulenLucas T. JaeXin WangEvelien DekkerJoan H. de JongMarnix Jansen
- Topics
- Mitochondrial Function and Pathology (5 papers)Cancer Cells and Metastasis (5 papers)Endoplasmic Reticulum Stress and Disease (4 papers)
- Partner nations
- NetherlandsGermanyUnited States
In The Last Decade
Evelyn Fessler
24 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Oncology 1.4k
- Molecular Biology 1.4k
- Cancer Research 656
- Pathology and Forensic Medicine 593
- Immunology 410
Countries citing papers authored by Evelyn Fessler
This map shows the geographic impact of Evelyn Fessler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evelyn Fessler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evelyn Fessler more than expected).
Fields of papers citing papers by Evelyn Fessler
This network shows the impact of papers produced by Evelyn Fessler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evelyn Fessler. The network helps show where Evelyn Fessler may publish in the future.
Co-authorship network of co-authors of Evelyn Fessler
This figure shows the co-authorship network connecting the top 25 collaborators of Evelyn Fessler. A scholar is included among the top collaborators of Evelyn Fessler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evelyn Fessler. Evelyn Fessler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 50 | |
| 3 | 41 | |
| 4 | 58 | |
| 5 | 60 | |
| 6 | 43 | |
| 7 | A pathway coordinated by DELE1 relays mitochondrial stress to the cytosolbreakdown → | 324 |
| 8 | 138 | |
| 9 | 33 | |
| 10 | 132 | |
| 11 | 120 | |
| 12 | 370 | |
| 13 | 46 | |
| 14 | 50 | |
| 15 | 91 | |
| 16 | 32 | |
| 17 | 202 | |
| 18 | Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesionsbreakdown → | 572 |
| 19 | 111 | |
| 20 | 260 |
About Evelyn Fessler
Evelyn Fessler is a scholar working on Cancer Research, Oncology and Cell Biology, having authored 24 papers that have together received 2.9k indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (5 papers), Cancer Cells and Metastasis (5 papers) and Endoplasmic Reticulum Stress and Disease (4 papers). The work is most often cited by research in Oncology (1.4k citations), Cancer Research (656 citations) and Pathology and Forensic Medicine (593 citations). Evelyn Fessler has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Jan Paul Medema, Felipe de Sousa e Melo, Louis Vermeulen, Lucas T. Jae, Xin Wang, Evelien Dekker, Joan H. de Jong, Marnix Jansen, Eva-Maria Eckl and Hans M. Rodermond. Their work appears in journals such as Nature, Journal of Clinical Investigation and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.